Meet Katharine Knobil, M.D., Agilent Technologies CMO

Katharine Knobil, M.D.'s Work History

Katharine Knobil has a distinguished career spanning over 25 years in pharmaceutical and biotech industries, focusing on clinical development, medical governance, and strategic leadership. She has contributed to the development of blockbuster medicines and has global experience in the U.S., Europe, and China.

• Apr 2025 — Chief Medical Officer, Altesa BioSciences
• Apr 2021 - Jan 2024 — Chief Medical Officer, Agilent Technologies
• Dec 2018 - Jan 2021 — Chief Medical Officer and Head of R&D, Kaleido Biosciences
• Dec 2017 - Dec 2018 — Chief Medical Officer, Pharmaceuticals, GSK
• Jun 2013 - Nov 2015 — SVP, Value Evidence and Outcomes, GSK
• Jun 2010 - Jun 2013 — VP, China Medicines Development, GSK
• Apr 2008 - Jun 2010 — VP, Respiratory Therapy Area Clinical Lead, GSK
• Jun 2005 - Apr 2008 — VP, Respiratory TA EU Clinical Head, GSK
• 2017 - 2018 — Board Member, National Health Council

Katharine Knobil, M.D.'s Education

Katharine Knobil earned her M.D. from the University of Texas Southwestern Medical School, completed a fellowship at Johns Hopkins University School of Medicine, and holds a B.A. from Cornell University.

• University of Texas Southwestern Medical School — Doctor of Medicine (MD)
• Johns Hopkins University School of Medicine — Fellow, Pulmonary and Critical Care
• Cornell University — Bachelor of Arts (B.A.)

How to Reach Katharine Knobil, M.D.?

You can reach Katharine Knobil, M.D. at *******@agilent technologies.com or by calling +1 **********. To get Katharine Knobil, M.D.'s contact information and other B2B leads like this, sign up for a free account at Anybody.com.